PTPN7 (protein tyrosine phosphatase non-receptor type 7) functions as a negative regulator of MAPK signaling pathways, specifically dephosphorylating and inactivating MAP kinases including ERK1/2 and p38 12. The protein plays critical roles in immune cell regulation, controlling T and B-lymphocyte development and signal transduction 3. PTPN7 operates through its phosphatase activity to modulate cellular processes including proliferation, differentiation, and immune responses 4. In platelets, PTPN7 serves as a negative regulator of ERK activation and thromboxane generation, controlling platelet functional responses downstream of G protein-coupled receptor agonists 2. The protein demonstrates significant clinical relevance, being overexpressed in various malignancies including gliomas where it correlates with tumor aggressiveness and poor prognosis 54. In gliomas, PTPN7 mediates macrophage polarization and immune evasion mechanisms 4. Additionally, PTPN7 expression is downregulated by inhaled corticosteroids as part of adaptive immunity suppression 3, and its expression decreases with aging in spermatozoa, potentially contributing to fertility decline 6.